Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Now, another step forward in obesity care here: FDA approved oral GLP-1 medications that expand how treatment can fit into peoples lives
Recombinant L lactis has been successful in delivering anti-inflammatory cytokines and other therapeutic molecules for conditions like inflammatory bowel disease and oral mucositis and reversing type 1 diabetes
Research Compound Summary Compound: BPC-157 CAS Number: 137525-51-0 Molecular Formula: C62H98N16O22 Purity: 99.41% (HPLC-UV verified) Third-Party Testing: Testides Analytical (independent lab, Toronto) COA Download: View Full COA (PDF) Report: DBAV-BPC-10-051226 Source: Canadian manufactured Shipping: Same-day from our BC facility BPC-157 peptide Canada: a synthetic pentadecapeptide derived from human gastric juice protein BPC (Body Protection Compound-157)
Coverage for GLP-1 medications under a POS plan will depend on whether your provider is in-network and whether prior authorization is required
